ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Generation of Potent Monocytic Myeloid-Derived Suppressor Cells from Rhesus Macaque Bone Marrow.

    A. Thomson, A. Zahorchak, A. Perez-Gutierrez, M. Ezzelarab.

    Surgery (Transplant), University of Pittsburgh, Pittsburgh, PA

    Background: Myeloid-derived suppressor cells (MDSC) have shown promise in inhibiting allograft rejection and in promoting transplant tolerance in rodent models. We recently reported that monocytic…
  • 2017 American Transplant Congress

    High Eomesodermin Expression Correlates with Potent Human Allo-Reactive CD8+ Effector T Cells.

    A. Perez-Gutierrez, D. Metes, Y. Ono, A. Thomson, M. Ezzelarab.

    Surgery, University of Pittsburgh, Pittsburgh, PA

    BackgroundThe transcription factors Eomesodermin (Eomes) and T-bet are thought to play critical roles in CD8+ effector memory T cell development. However, the role of Eomes…
  • 2017 American Transplant Congress

    CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute Kidney Allograft Rejection.

    L. Schiffer,1 F. Wiehler,1 M. Daemmrich,2 K. Hueper,3 M. Mengel,4 A. Thorenz,1 S. von Vietinghoff,1 R. Song,1 M. Schiffer,1 F. Gueler.1

    1Nephrology, Hannover Medical School, Hannover, Germany; 2Pathology, Hannover Medical School, Hannover, Germany; 3Radiology, Hannover Medical School, Hannover, Germany; 4Laboratory Medicine & Pathology, University of Alberta, Edmonton, Canada

    The majority of kidney allograft rejections are T cell mediated (TCMR). However, it has been shown that in the presence of B-cell clusters the course…
  • 2017 American Transplant Congress

    Autotransplantation of the Left Lung for the Treatment of Recurrent Life Threatening Pulmonary Hemorrhage Related to Pulmonary Vascular Malformation: A Unique Chance to Study Ischemia/Reperfusion Injury.

    C. Falk,1 I. Tudorache,2 C. Müller,3 W. Sommer,2 K. Daemen,1 J. Keil,1 G. Hansen,3 A. Haverich,2 G. Warnecke,2 N. Schwerk.3

    1Institute of Transplant Immunology, IFB-Tx, MHH, Hannover, Germany; 2Department of Cardiothoracic Transplant and Vascular Surgery, MHH, Hannover, Germany; 3Department of Pediatric Pneumology, MHH, Hannover, Deutschland, Germany

    Background: Ischemia reperfusion injury (IRI) remains a major clinical problem in lung transplantation. Here, we report the investigation of IRI in a 17-year-old patient who…
  • 2017 American Transplant Congress

    Clinical Impact of Strength and Class of Pre transplant Donor Specific Antibody on Kidney Transplant Recipient Receiving Steroid Free Maintenance Immunosupression Regimen.

    O. Adebiyi, O. Simo, S. Hussain, D. Mishler, W. Goggins, T. Taber, A. Sharfuddin, M. Yaqub.

    Renal Transplant, Indiana University School of Medicine, Indianapolis, IN

    Background: The class and strength of pre- transplant DSA has been described as playing a role in determining future risk of acute rejection (AR) and…
  • 2017 American Transplant Congress

    Optimization of Extended-Release Tacrolimus Dose with Mycophenolate Mofetile Based Immunosuppression in De Novo Kidney Transplant Recipients: 2 Years Outcome.

    Y. Watarai,1 S. Narumi,1 M. Okada,1 R. Kimura,1 K. Hatazoe,1 K. Futamura,1 T. Yamamoto,1 T. Hiramitsu,1 M. Tsujita,1 N. Goto,1 T. Kobayashi.2

    1Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan; 2Kidney Transplant Surgery, Aichi Medical University, Nagakute, Aichi, Japan

    Purpose: Once-daily tacrolimus extended-release formulation (TACER) has been accepted in kidney transplantation, however its optimal dosing are not well determined. We have validated the institutional…
  • 2017 American Transplant Congress

    Single-Center, Prospective, Open Label Pilot Study to Investigate the Effectiveness of Everolimus Associated with Mycophenolic Acid and Prednisone in Adult Patients Submitted to an Allograft Renal Transplant with Calcineurin Inhibitor Withdrawl on Week 16th.

    L. Giordano,1,2 M. Lasmar,1,2 H. Vianna,1,2 E. Lasmar.1,2

    1Renal Transplant Unit, Hospital Universitário Ciências Médicas de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; 2Nephrology Department, Rede Mater Dei de Saúde, Belo Horizonte, Minas Gerais, Brazil

    Although CI have proven efficacy in kidney transplantation worldwide, they are drugs with nephrotoxic potential and may contribute to chronic renal allograft nephropathy. As a…
  • 2017 American Transplant Congress

    A Prospective Observational Study to Evaluate Use of a Panel of Reactive T Cell (PRT) Assay as a Pre-Transplant Marker of Rejection in Kidney Transplant Recipients.

    D. Brennan,1 L. Kayler,2 D. Wojciechowski,3 A. Limaye,4 A. Gaber,5 I. Durrant.6

    1Washington University, St. Louis, MO; 2Erie County Medical Center, Buffalo, NY; 3Massachusetts General Hospital, Boston, MA; 4Washington University, Seattle, WA; 5Houston Methodist, Houston, TX; 6Oxford Immunotec, Oxfordshire, United Kingdom

    Background:To assess risk of T cell mediated acute rejection a recently developed assay uses a panel of reactive T cell lines (PRT) to measure recipient…
  • 2017 American Transplant Congress

    Cyclosporine Effects on Blood Pressure Are Exaggerated in Pubertal Girls After Renal Transplantation.

    A. Melk,1 R. Sugianto,1 B. Schmidt,2 K. Krupka,3 B. Höcker,3 B. Tönshoff,3 E. Wühl.3

    1Pediatric Nephrology, Hannover Medical School, Hanover, Germany; 2Nephrology, Hannover Medical School, Hanover, Germany; 3Pediatric Nephrology, University of Heidelberg, Heidelberg, Germany

    Hypertension is a common problem after renal transplantation. We investigated potential contributing factors for high blood pressure (BP) in 336 pediatric transplant recipients from the…
  • 2017 American Transplant Congress

    Persistent Hypophosphatemia Among Deceased-Donor Kidney Transplant Recipients Is Donor-Dependent and Associated with Superior Long-Term Allograft Outcomes.

    N. Otto, T. Schachtner, P. Reinke.

    Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany

    Significant variations in posttransplant phosphate levels are recognized after kidney transplantation, and associated with more favorable allograft outcomes. Although posttransplant hypophosphatemia may be associated with…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences